Plasma concentrations of fluticasone propionate and budesonide following inhalation: Effect of induced bronchoconstriction

British Journal of Clinical Pharmacology

Volumn 64, Issue 4, 2007, Pages 439-444

  Mortimer, Kevin J ^a,c   Tattersfield, Anne E ^a   Tang, Yufei ^b   Wu, Kai ^b   Lewis, Sarah ^a   Hochhaus, Gunther ^b   Harrison, Tim W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF FLORIDA   (United States)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Asthma; Inhaled corticosteroid; Pharmacology

Indexed keywords

ACCUHALER; BUDESONIDE; FLUTICASONE PROPIONATE; METHACHOLINE; TURBOHALER; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BLOOD LEVEL; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, INHALATION; ADULT; AGED; ANDROSTADIENES; ASTHMA; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; BUDESONIDE; CROSS-OVER STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34548631672     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02856.x     Document Type: Article

References (18)

1. Todd GRG, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002 87 : 457 61.
2. Wong CA, Walsh LJ, Smith CJP, Wisniewski AF, Lewis SA, Hubbard R, Cawte S, Green DJ, Pringle M, Tattersfield AE. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000 355 : 1399 403.
3. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001 345 : 941 7.
4. Hubbard RB, Smith CJP, Smeeth L, Harrison TW, Tattersfield AE. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med 2002 166 : 1563 6.
5. Smeeth L, Boulis M, Hubbard R, Fletcher AE. A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol 2003 87 : 1247 51.
6. Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Ohlsson SV. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999 340 : 1948 53.
7. Winkler J, Hochhaus G, Derendorf H. How the lung handles drugs pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc 2004 1 : 356 63.
8. Brutsche MH, Brutsche IC, Munavvar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet 2000 356 : 556 61.
9. Harrison TW, Tattersfield AE. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax 2003 58 : 258 60.
10. Singh SD, Whale C, Houghton N, Daley-Yates P, Kirby SM, Woodcock AA. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease. Br J Clin Pharmacol 2003 55 : 375 81.
11. Standardised lung function testing. Bull Europ Physiopath Resp 1983 19 (Suppl 5 1 95.
12. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983 38 : 760 5.
13. Dimova H, Wang Y, Pommery S, Moellmann H, Hochhaus G. SPE/RIA vs LC/MS for measurement of low levels of budesonide in plasma. Biomed Chromatogr 2003 17 : 14 20.
14. Krishnaswami S, Mollmann H, Derendorf H, Hochhaus G. A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma. J Pharmaceut Biomed Anal 2000 22 : 123 9.
15. Saari SM, Vidgren MT, Koskinen MO, Turjanmaa VM, Waldrep JC, Nieminen MM. Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma. Chest 1998 113 : 1573 9.
16. Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996 97 : 169 76.
17. Thorsson L, Edsbacker S, Conrandson TB. Lung deposition of budesonide from Turbohaler is twice that from a pressurized metered-dose inhaler (p-MDI). Eur Respir J 1994 7 : 1839 44.
18. Agertoft L, Pedersen S. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children. Am J Respir Crit Care Med 2003 168 : 779 82.